# The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth:

> **NCT07305519** · NA · RECRUITING · sponsor: **University of Roma La Sapienza** · enrollment: 150 (estimated)

## Conditions studied

- Preterm Labor

## Interventions

- **DRUG:** Magnesium-PEA-HMW Hyaluronic Acid-Vitamin B6-Vitamin D + Vaginal Progesterone
- **OTHER:** Standard Treatment (Guideline-Based)

## Key facts

- **NCT ID:** NCT07305519
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-04-01
- **Final completion:** 2028-01-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07305519

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07305519, "The Combined Effect of Magnesium, Palmitoylethanolamide, High-Molecular-weight Hyaluronic Acid, Vitamin B6, and Vitamin D in Preventing Preterm Birth:". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT07305519. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*